Skip to main content
. 2017 May 3;2017(5):CD011986. doi: 10.1002/14651858.CD011986.pub2

COMPARE ACUTE.

Trial name or title Comparison Between FFR Guided Revascularisation Versus Conventional Strategy in Acute STEMI Patients with MVD (CompareAcute).
Methods Open‐label RCT.
Participants People with acute STEMI and MVD.
Interventions FFR‐guided revascularisation strategy vs culprit vessel only intervention.
Outcomes Primary: composite endpoint of all‐cause mortality, non‐fatal myocardial infarction, any revascularisation, and cerebrovascular events (MACCE) at 12 months between groups.
Secondary: composite endpoint of cardiac death, myocardial infarction, revascularisation, stroke and major bleeding, composite of hospitalisation for heart failure and unstable angina pectoris, all‐cause mortality, stent thrombosis, bleeding, treatment costs, and each component of the primary endpoint.
Starting date May 2011.
Contact information Steffen Helqvist.
Notes www.ClinicalTrial.gov NCT01399736.